Sucampo Pharmaceuticals (SCMP +6%) gets a boost this morning from Maxim initiating the shares with a Buy rating and a price target of $10. The stock actually began trending higher last week after TheStreet.com mentioned it as one of five sub-$10 stocks that are triggering technical breakouts.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs